Clinical Trial Update: Peptide Vaccination With PD-L1 and PD-L2 Peptides in Untreated Chronic Lymphatic Leukemia. [Phase 2]

View source ↗

Summary

Phase 2 trial updating peptide vaccination targeting PD-L1 and PD-L2 in untreated chronic lymphocytic leukemia (Chronic Lymphocytic Leukemia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Peptide vaccination targeting PD-L1 and PD-L2

Snippet

Sponsor: Lars Møller Pedersen | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED